Janos Paloczi

Has grant

assistant professor

Louisiana State University Health Sciences Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Janos Paloczi is an assistant professor at Louisiana State University Health Sciences Center New Orleans in the United States. His research focuses on the effects of alcohol on cardiovascular health, liver function, and the therapeutic potential of cannabinoid receptors. He has contributed to multiple articles examining the biological mechanisms underlying alcohol-related damage and novel targets for treatment in age-related diseases.

Recent Grants

Grant: Close

The role of gut-heart axis in acute alcohol intoxication-induced adverse cardiovascular events

Open Date: 2023-08-01

Close Date: 2026-07-31

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (4)

Luca Maccioni

National Institute on Alcohol Abuse and Alcoholism

UNITED STATES

View details

Youngchan Kim

University of Surrey

UNITED KINGDOM

View details

Márton Tokodi

Semmelweis University

HUNGARY

View details

Pal Pacher

Laboratory Chief

National Institutes of Health

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Janos Paloczi

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Commentary on “Effects of at‐risk alcohol use on nighttime blood pressure, urinary catecholamines, and sleep quality in midlife adults”

Coordinated action of a gut–liver pathway drives alcohol detoxification and consumption

PCSK9, A Promising Novel Target for Age-Related Cardiovascular Dysfunction

Editorial: Biophysics approaches to investigate multi-organ alcohol-induced damage

Abstinence Restores Cardiac Function in Mice with Established Alcohol-Induced Cardiomyopathy

A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence

Data-driven transcriptomics analysis identifies PCSK9 as a novel key regulator in liver aging.

Organ-specific model of simulated ischemia/reperfusion and hyperglycemia based on engineered heart tissue.

Structural basis of selective cannabinoid CB<sub>2</sub> receptor activation.

Correction to: Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis

Collaborators (4)

Luca Maccioni

Youngchan Kim

Márton Tokodi

Pal Pacher

Make your next move.